BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9619059)

  • 21. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
    Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
    Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens.
    Fiel MI; Cernaianu G; Burstein DE; Batheja N
    Acta Cytol; 1996; 40(4):637-41. PubMed ID: 8693878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of intratesticular endometrioid papillary cystadenocarcinoma.
    Numakura K; Tsuchiya N; Tsuruta H; Obara T; Saito M; Inoue T; Narita S; Horikawa Y; Satoh S; Nanjyo H; Habuchi T
    Jpn J Clin Oncol; 2011 May; 41(5):674-6. PubMed ID: 21474549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
    Wallace ML; Longacre TA; Smoller BR
    Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovarian carcinomas.
    Halperin R; Zehavi S; Dar P; Habler L; Hadas E; Bukovsky I; Schneider D
    Eur J Gynaecol Oncol; 2001; 22(4):292-6. PubMed ID: 11695812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic lymphadenopathy as the primary symptom of serous surface papillary carcinoma of the ovary.
    Chen CA; Huang SH; How SW; Hsieh CY
    Gynecol Oncol; 1995 Aug; 58(2):251-4. PubMed ID: 7622114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory breast metastases of ovarian cancer: a case report.
    Kayikçioğlu F; Boran N; Ayhan A; Güler N
    Gynecol Oncol; 2001 Dec; 83(3):613-6. PubMed ID: 11733984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastases to breast simulating ductal carcinoma in situ: report of two cases and review of the literature.
    Gupta D; Merino MI; Farhood A; Middleton LP
    Ann Diagn Pathol; 2001 Feb; 5(1):15-20. PubMed ID: 11172202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian carcinoma with simultaneous breast and rectum metastases.
    Derin D; Eralp Y; Guney N; Ozlük Y; Topuz E
    Onkologie; 2008 Apr; 31(4):200-2. PubMed ID: 18418023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
    Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apocrine ductal carcinoma in-situ with an unusual morphological presentation.
    Coyne JD
    Histopathology; 2001 Mar; 38(3):280. PubMed ID: 11260313
    [No Abstract]   [Full Text] [Related]  

  • 32. [Breast metastases of an ovarian adenocarcinoma].
    Martel J; Roux JJ; Treilleux I; Bouchet P; Froger X; Mechin-Cretinon I
    Ann Dermatol Venereol; 2003; 130(6-7):623-5. PubMed ID: 13679699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
    Lee BH; Hecht JL; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral inflammatory breast metastases of epithelial ovarian cancer.
    Ozgüroğlu M; Ersavaşti G; Ilvan S; Hatemi G; Demir G; Demirelli FH
    Am J Clin Oncol; 1999 Aug; 22(4):408-10. PubMed ID: 10440201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastasis to the breast from an ovarian carcinoma.
    Petersen BL; Høgdall E; Kryger-Baggesen N
    Acta Obstet Gynecol Scand; 1999 Oct; 78(9):826-7. PubMed ID: 10535351
    [No Abstract]   [Full Text] [Related]  

  • 36. Progesterone-binding cyst protein (PBCP = GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer. Inverse relation of distribution in normal and malignant tissue of the same breast.
    Søreide JA; Lea OA; Kvinnsland S
    Anticancer Res; 1991; 11(3):1323-6. PubMed ID: 1888167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infiltrating lobular carcinoma of the breast with histiocytoid features: three cases].
    Augros M; Buénerd A; Devouassoux-Shisheboran M; Berger G
    Ann Pathol; 2004 Jun; 24(3):259-63; quiz 227. PubMed ID: 15480261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive parameters for internal mammary node drainage in patients with early breast cancer.
    Lukesova L; Vrana D; Gatek J; Koranda P; Cwiertka K; Radova L; Melichar B; Prouzova Z; Sramek V; Svach I
    Tumori; 2014; 100(3):254-8. PubMed ID: 25076234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucinous carcinoma of the eyelid. An immunohistochemical study.
    Carson HJ; Gattuso P; Raslan WF; Reddy V
    Am J Dermatopathol; 1995 Oct; 17(5):494-8. PubMed ID: 8599456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast carcinoma metastasis within granulosa cell tumor of the ovary: morphologic, immunohistologic, and molecular analyses of the two different tumor cell populations.
    Arnould L; Franco N; Soubeyrand MS; Mege F; Belichard C; Lizard-Nacol S; Collin F
    Hum Pathol; 2002 Apr; 33(4):445-8. PubMed ID: 12055682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.